Sandbox:Pulmonary valve stenosis

Jump to navigation Jump to search


Overview

Historical Perspective

Epidemiology and Demographics

  • In Asian countries the prevalence of pulmonic stenosis and tetralogy of fallot is higher when compared to white children.[1]
  • Incidence of isolated PS is 1.5-6.5 per 10,000live births and accounts for 2 to 13% of all congenital heart lesions.

Causes

Pulmonary valve stenosis is due to a structural changes resulting from thickening and fusion of the pulmonary valve. The valve pathology can be congenital or acquired. The following is the list of causes:

  • Congenital causes: Account for 95% of the cases with pulmonic stenosis, they include isolated pulmonic valve pathologies and associations with other congenital heart diseases.
    • Associated with congenital heart disease:
      • Tetralogy of Fallot
      • Double outlet right ventricle
      • Univentricular atrio-ventricular connection
      • Atrioventricular canal defect
      • Bicuspid pulmonary valve: Frequently associated with Tetralogy of Fallot.
      • Quadricuspid pulmonary valve: It is a benign and an incidental finding.
    • Isolated pulmonic stenosis: The causes include as follows:
      • Acommissural pulmonary valves: Valve has a prominent systolic doming of the cusps and an eccentric orifice.
      • Dysplastic pulmonary valves: Thickened and deformed cusps with no commissural fusion.
      • Less common malformations include of commissural malformation include: unicommissural pulmonary valve, bicuspid valve with fused commissures.
  • Acquired Causes: These are less frequent and account for less than 5% of the cases.
    • Carcinoid Syndrome: It is the most common acquired cause of Pulmonic stenosis.
    • Post infectious: Infective endocarditis
    • Rheumatic heart disease
  • Functional Pulmonic Stenosis:

Risk Factors

Common risk factors in the development of congenital heart disease, apply for pulmonic stenosis and include:

  • Maternal pre-gestational diabetes mellitus
  • Consanguineous marriage
  • Phenylketonuria
  • Febrile illness
  • Vitamin A use
  • Marijuana use
  • Exposure to organic solvents

Pathophysiology

Anatomy

  • Pulmonary valve is located at the distal part of the right ventricular outflow tract at the junction of the pulmonary artery.
  • It is located anterior and superior to the aortic valve at the level of the third intercostal space and separated from the tricuspid valve by the infundibulum of the right ventricle.
  • It is comprised of three equal sized, semilunar cusps or leaflets (right, left, anterior), nomenclature based on the corresponding aortic valve.
  • The three cusps are joined by commissures and the cusps are thinner when compared to the aortic valve, due to a low pressure in the right ventricle.
  • The area of the valve is related to body surface area and men usually have greater valve area when compared with women.[2]
  • The normal orifice area is approximately around 3cm².[3]
  • The pulmonary valve opens in the right ventricular systole allowing the deoxygenated blood to be delivered to the lungs.
  • During the right ventricular diastole the pulmonary valves close completely to prevent regurgitation of blood into the right ventricle.

Pathogenesis

  • Pulmonic valve stenosis can result from structural alterations resulting from congenital and acquired causes.

Genetics

Associated Conditions

These are a common genetic disorders associated with pulmonic stenosis:[4]

Syndrome Genetic Defect Cardiac features Other features
Noonan
  • PTPN11, SOS1
  • Heterogeneous trait
  • Aberrant RAS-MAPK-signaling
  • Dysplastic pulmonary valve stenosis
  • Supravalvular pulmonary stenosis
  • Hypertrophic cardiomyopathy
  • Short stature
  • Hypertelorism
  • Downward eye slant
  • Low set ears
Williams Beuren
  • 7Q11.23 deletions
  • Autosomal dominant trait
  • Supravalvular aortic or pulmonary stenosis
  • Elfin face
  • Short stature
  • Impaired cognition and development
  • Endocrine disorders and genitourinary abnormalities
Leopard
  • PTPN11, RAF-1
  • Autosomal dominant trait
  • Electrocardiographic abnormalities
  • Supravalvular or valvular pulmonary stenosis
  • Lentigines
  • Ocular hypertelorism
  • Abnormal genitalia
  • Retardation of growth
  • Deafness
DiGeorge
  • 22Q11 deletion
  • Autosomal dominant trait
  • Conotruncal defects such as tetralogy of Fallot
  • Interrupted aortic arch
  • Truncus arteriosus
  • Vascular rings
  • ASD/VSD
  • Hypertelorism
  • Low set and posteriorly rotated ears
  • Palatal abnormalities
  • Micrognathia
  • Developmental delay
  • Hypoplastic thymus
  • Hypocalcaemia
  • Immunological abnormalities
Allagile
  • AG-1, NOTCH-2
  • Dominant trait
  • Peripheral pulmonary stenosis
  • Facial dysmorphias (triangular face, wide nasal bridge, deep set eyes)
  • Intrahepatic cholestasis
  • Butterfly vertebrae
Keutel
  • MGP mutations
  • Autosomal recessive trait
  • Multiple peripheral pulmonary stenosis
  • Abnormal cartilage calcifications
  • Brachytelephalangy
  • Subnormal IQ and hearing loss
Congenital Rubella N/A
  • Peripheral pulmonary stenosis
  • Open ductus Botalli
  • Congenital cataract/glaucoma
  • Deafness
  • Pigmentary retinopathy

History, Symptoms

Physical Examination

Diagnosis

Treatment

Guidelines

Medical Therapy

Surgical Therapy

Follow up

Prevention

Reflist</2> Template:WH Template:WS

  1. Jacobs EG, Leung MP, Karlberg J (2000). "Distribution of symptomatic congenital heart disease in Hong Kong". Pediatr Cardiol. 21 (2): 148–57. doi:10.1007/s002469910025. PMID 10754087.
  2. Capps SB, Elkins RC, Fronk DM (2000). "Body surface area as a predictor of aortic and pulmonary valve diameter". J Thorac Cardiovasc Surg. 119 (5): 975–82. doi:10.1016/S0022-5223(00)70092-4. PMID 10788818.
  3. Singh B, Mohan JC (1992). "Doppler echocardiographic determination of aortic and pulmonary valve orifice areas in normal adult subjects". Int J Cardiol. 37 (1): 73–8. PMID 1428292.
  4. Pierpont ME, Basson CT, Benson DW, Gelb BD, Giglia TM, Goldmuntz E; et al. (2007). "Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics". Circulation. 115 (23): 3015–38. doi:10.1161/CIRCULATIONAHA.106.183056. PMID 17519398.